Clicks GroupCLCGY +0.49%83 Return-on-Tangible-Equity is 60.79% as of Feb. 2026, which is 13% above its 10-year median of 53.73. GuruFocus rates CLCGY with a GF Score™ of 83/100 and a GF Value™ of $46.21 (Significantly Undervalued). Among 582 Healthcare Providers & Services companies, Clicks Group ranks better than 83.68% on this metric.
Return-on-Tangible-Equity is calculated as Net Income divided by its average total shareholder tangible equity. Total shareholder tangible equity equals to Total Stockholders Equity minus Intangible Assets. Clicks Group's annualized net income for the quarter that ended in Feb. 2026 was $191 Mil. Clicks Group's average shareholder tangible equity for the quarter that ended in Feb. 2026 was $315 Mil. Therefore, Clicks Group's annualized Return-on-Tangible-Equity for the quarter that ended in Feb. 2026 was 60.79%.
The historical rank and industry rank for Clicks Group's Return-on-Tangible-Equity or its related term are showing as below:
CLCGY'
s Return-on-Tangible-Equity Range Over the Past 10 Years
Min: 42.41 Med: 53.73 Max: 63.81
Current: 62.92
During the past 13 years, Clicks Group's highest Return-on-Tangible-Equity was 63.81%. The lowest was 42.41%. And the median was 53.73%.
CLCGY's Return-on-Tangible-Equity is ranked better than 83.68% of 582
companies
in the Healthcare Providers & Services industry
Industry Median: 10.065
vs CLCGY: 62.92
Clicks Group (OTCPK:CLCGY) Return-on-Tangible-Equity Explanation
Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.
Be Aware
Net Income is used.
Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.
Clicks Group Return-on-Tangible-Equity Related Terms
Clicks Group Return-on-Tangible-Equity Historical Data
* Premium members only.
The historical data trend for Clicks Group's Return-on-Tangible-Equity can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Clicks Group Return-on-Tangible-Equity Competitor Comparison
For the Pharmaceutical Retailers subindustry, Clicks Group's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Clicks Group Return-on-Tangible-Equity vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Clicks Group's Return-on-Tangible-Equity distribution charts can be found below:
* The bar in red indicates where Clicks Group's Return-on-Tangible-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is two times the semi-annual (Feb. 2026) net income data.
Return-on-Tangible-Equity is displayed in the 10-year financial page.
What does a Return-on-Tangible-Equity of 60.79% mean?
Clicks Group (CLCGY) has a Return-on-Tangible-Equity of 60.79% as of Feb. 2026. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Clicks Group and its competitors. This is 13% above median its historical median of 53.73. Over the past decade, Clicks Group's Return-on-Tangible-Equity has ranged from 42.41 to 63.81. According to the industry distribution chart, Clicks Group ranks #95 out of 582 companies in the Healthcare Providers & Services industry, placing it in the top 16.3%.
Is Clicks Group's Return-on-Tangible-Equity too high?
Clicks Group's current Return-on-Tangible-Equity of 60.79% is 13% above median its 10-year median of 53.73. Over the past 10 years, this metric has ranged from a low of 42.41 to a high of 63.81. The Healthcare Providers & Services industry median Return-on-Tangible-Equity is 10.07. Clicks Group's value of 60.79% is 504% above this industry median. Based on the distribution chart, Clicks Group ranks #95 out of 582 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Clicks Group has a GF Score™ of 83/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Clicks Group's Return-on-Tangible-Equity compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, Clicks Group ranks #95 out of 582 companies for Return-on-Tangible-Equity. This places Clicks Group in the top 16% of its industry — outperforming the majority of peers. The industry median Return-on-Tangible-Equity is 10.07. Clicks Group's value of 60.79% is 504% above this benchmark. Historically, Clicks Group's own Return-on-Tangible-Equity has ranged from 42.41 to 63.81 over the past decade. While the company's 10-year median is 53.73 vs. the industry median of 10.07, Clicks Group has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Equity for a Healthcare Providers & Services company?
The median Return-on-Tangible-Equity among Healthcare Providers & Services companies is 10.07, based on 582 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Equity significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Clicks Group's current Return-on-Tangible-Equity of 60.79% is 504% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Equity mean?
A high Return-on-Tangible-Equity can signal that a stock is expensive relative to its fundamentals. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Clicks Group and its competitors. For the Healthcare Providers & Services industry, the median Return-on-Tangible-Equity is 10.07 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Clicks Group's current Return-on-Tangible-Equity is 60.79%, which is 13% above median its own 10-year median of 53.73. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Clicks Group stock overvalued right now?
Based on GuruFocus' analysis, Clicks Group (CLCGY) is currently considered Significantly Undervalued. The stock's GF Value™ is $46.21, compared to a current price of $28.59 — trading 38.1% below its estimated fair value. The current Return-on-Tangible-Equity is 60.79%, which is 13% above median its 10-year median of 53.73 and 504% above the Healthcare Providers & Services industry median of 10.07. Clicks Group's overall GF Score™ is 83/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Equity calculated?
Return-on-Tangible-Equity is calculated from a company's financial statements. For Clicks Group (CLCGY), the current Return-on-Tangible-Equity is 60.79% as of Feb. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Clicks Group (CLCGY) Overvalued in 2026?
Based on GuruFocus' analysis, Clicks Group stock appears to be undervalued.
The current stock price of $28.59 is trading 38.1% below its estimated GF Value™ of $46.21.
GuruFocus considers Clicks Group to be Significantly Undervalued.
Key valuation signals for CLCGY:
Return-on-Tangible-Equity: 60.79% (13% above median its 10-year median of 53.73)
GF Value™: $46.21 vs. price of $28.59 (38.1% below fair value)
Industry Position: 504% above the Healthcare Providers & Services median (#95 of 582)
No single metric tells the full story. See the CLCGY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Clicks Group Ltd operates prominently in health, beauty, and wellness retail across southern Africa. The company predominantly operates a retail pharmacy chain in South Africa, with a limited number of operations in bordering countries. The company has a portfolio of retail franchise brands including The Body Shop, M-Kem, and Sorbet among others. The company's business segments include Retail and Distribution. The company generates revenue from in-store and online sales of health, beauty, and wellness items, plus wholesale pharmaceutical distribution. Geographically, the maximum revenue is generated from South Africa.
83GF Score
Get the complete analysis for CLCGY
Return-on-Tangible-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CLCGY has been successfully added to your 
